A new and short protocol to achieve the early diagnosis of mild cognitive impairment.


Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 14 06 2020
accepted: 04 01 2021
pubmed: 15 1 2021
medline: 7 9 2021
entrez: 14 1 2021
Statut: ppublish

Résumé

The mild cognitive impairment (MCI) is a neurocognitive disorder which involves cognitive impairments beyond those expected for the age and education of the subject but are not significant enough to interfere with instrumental activities of daily living. The identification of individuals with MCI is particularly important for those who might benefit from new therapies. The aim of this work is to propose a comprehensive neuropsychological protocol to achieve early diagnosis of MCI. A neuropsychological battery was created and administered to a sample of patients with MCI (n = 25) and healthy matched controls (n = 25). Although memory decline is often the first sign preceding the appearance of MCI, significant differences in visuospatial tasks, naming abilities, and executive function can be demonstrated as well between MCI and controls. A proper selection of cognitive measures within those included in the already-available neuropsychological batteries may provide a thorough assessment of MCI and allow its timely diagnosis.

Identifiants

pubmed: 33442844
doi: 10.1007/s10072-021-05044-1
pii: 10.1007/s10072-021-05044-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3687-3694

Subventions

Organisme : Ministerio de Economía y Competitividad
ID : CTQ2014-58826-R
Organisme : Gobierno del Principado de Asturias
ID : FC-15-GRUPIN14-021

Informations de copyright

© 2021. Fondazione Società Italiana di Neurologia.

Références

Murman DL (2015) The impact of age on cognition. Semin Hear 36(3):111–121. https://doi.org/10.1055/s-0035-1555115
doi: 10.1055/s-0035-1555115 pubmed: 27516712 pmcid: 4906299
Kral VA (1962) Senescent forgetfulness: benign and malignant. Can Med Assoc J 86(6):257–260
pubmed: 14459267 pmcid: 1848846
Reisberg B, Ferris SH, de Leon MJ, Crook T (1982) The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 139(9):1136–1139. https://doi.org/10.1176/ajp.139.9.1136
doi: 10.1176/ajp.139.9.1136 pubmed: 7114305
Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256(3):183–194. https://doi.org/10.1111/j.1365-2796.2004.01388.x
doi: 10.1111/j.1365-2796.2004.01388.x pubmed: 15324362
Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, Zamora D, Goodkinf M, Bell K, Stern Y, Devanand DP (2006) Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry 63(8):916–924. https://doi.org/10.1001/archpsyc.63.8.916
doi: 10.1001/archpsyc.63.8.916 pubmed: 16894068
Schmidtke K, Hermeneit S (2008) High rate of conversion to Alzheimer’s disease in a cohort of amnestic MCI patients. Int Psychogeriatr 20(1):96–108. https://doi.org/10.1017/S1041610207005509
doi: 10.1017/S1041610207005509 pubmed: 17506911
Bozoki A, Giordani B, Heidebrink JL, Berent S, Foster NL (2001) Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Arch Neurol 58(3):411–416. https://doi.org/10.1001/archneur.58.3.411
doi: 10.1001/archneur.58.3.411 pubmed: 11255444
Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27(3):349–356. https://doi.org/10.1002/mds.24893
doi: 10.1002/mds.24893 pubmed: 22275317 pmcid: 3641655
Goldman JG, Holden S, Ouyang B, Bernard B, Coetz CG, Sebbins GT (2014) Diagnosing PD-MCI by task force criteria: how many and which neuropsychological tests? Mov Disord 30(3):402–406. https://doi.org/10.1002/mds.26084
doi: 10.1002/mds.26084 pubmed: 25449653 pmcid: 4357536
Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Lawrence Earlbaum Associates, Hillsdale
Seigerschmidt E, Mösch E, Siemen M, Förstl H, Bickel H (2002) The clock drawing test and questionable dementia: reliability and validity. Int J Geriatr Psychiatry 17(11):1048–1054. https://doi.org/10.1002/gps.747
doi: 10.1002/gps.747 pubmed: 12404654
Forti P, Olivelli V, Rietti E, Maltoni B, Ravaglia G (2010) Diagnostic performance of an executive clock drawing task (CLOX) as a screening test for mild cognitive impairment in elderly persons with cognitive complaints. Dement Geriatr Cogn Disord 30(1):20–27. https://doi.org/10.1159/000315515
doi: 10.1159/000315515 pubmed: 20606441
Ehreke L, Luck T, Luppa M, König HH, Villringer A, Riedel-Heller SG (2011) Clock drawing test – screening utility for mild cognitive impairment according to different scoring systems: results of the Leipzig Longitudinal Study of the Aged (LEILA 75+). Int Psychogeriatr 23(10):1592–1601. https://doi.org/10.1017/S104161021100144X
doi: 10.1017/S104161021100144X pubmed: 21813037
Cacho J, García-García R, Arcaya J, Vicente JL, Lantada N (1999) Una propuesta de aplicación y puntuación del test del reloj en la enfermedad de Alzheimer. Rev Neurol 28:648–655
pubmed: 10363287
Hodges JR, Patterson K (1995) Is semantic memory consistently impaired early in the course of Alzheimer’s disease? Neuroanatomical and diagnostic implications. Neuropsychologia 33(4):441–459. https://doi.org/10.1016/0028-3932(94)00127-b
doi: 10.1016/0028-3932(94)00127-b pubmed: 7617154
Welsh KA, Butters N, Hughes JP, Mohs RC, Heyman A (1992) Detection and staging of dementia in Alzheimer’s disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer’s Disease. Arch Neurol 49(5):448–452. https://doi.org/10.1001/archneur.1992.00530290030008
doi: 10.1001/archneur.1992.00530290030008 pubmed: 1580805
Welsh K, Butters N, Hughes J, Mohs R, Heyman A (1991) Detection of abnormal memory decline in mild cases of Alzheimer’s disease using CERAD neuropsychological measures. Arch Neurol 48(3):278–281. https://doi.org/10.1001/archneur.1991.00530150046016
doi: 10.1001/archneur.1991.00530150046016 pubmed: 2001185
Albert MS, Moss MB, Tanzi R, Jones K (2001) Preclinical prediction of AD using neuropsychological tests. J Int Neuropsychol Soc 7(5):631–639. https://doi.org/10.1017/S1355617701755105
doi: 10.1017/S1355617701755105 pubmed: 11459114
Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Brit J Psychiatry 140:566–572. https://doi.org/10.1192/bjp.140.6.566
doi: 10.1192/bjp.140.6.566
Troyer AK, Moscovitch M, Winocur G, Leach L, Freedman M (1998) Clustering and switching on verbal fluency tests in Alzheimer’s and Parkinson’s disease. J Int Neuropsychol Soc 4(2):137–143. https://doi.org/10.1017/s1355617798001374
doi: 10.1017/s1355617798001374 pubmed: 9529823
Rosen WG (1980) Verbal fluency in aging and dementia. J Clin Neurosci 2(2):135–146
Monsch AU, Bondi MW, Butters N, Salmon DP, Katzman R, Thal LJ (1992) Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer type. Arch Neurol 49(12):1253–1258
doi: 10.1001/archneur.1992.00530360051017
Piatt AL, Fields JA, Paolo AM, Tröster AI (1999) Action (verb naming) fluency as an executive function measure: convergent and divergent evidence of validity. Neuropsychologia. 37(13):1499–1503
doi: 10.1016/S0028-3932(99)00066-4
Piatt AL, Fields JA, Paolo AM, Tröster AI (2004) Action verbal fluency normative data for the elderly. Brain Lang 89(3):580–583
doi: 10.1016/j.bandl.2004.02.003
Sgaramella TM, Borgo F, Mondini S, Pasini M, Toso V, Semenza C (2001) Executive deficits appearing in the initial stage of Alzheimer’s disease. Brain Cogn 46(1–2):264–268
doi: 10.1016/S0278-2626(01)80080-4
Perry RJ, Hodges JR (1999) Attention and executive deficits in Alzheimer’s disease. A critical review. Brain J Neurol 122(3):383–404
doi: 10.1093/brain/122.3.383
Griffith HR, Netson KL, Harrell LE, Zamrini EY, Brockington JC, Marson DC (2006) Amnestic mild cognitive impairment: diagnostic outcomes and clinical prediction over a two-year time period. J Int Neuropsychol Soc 12(02)
Kramer JH, Nelson A, Johnson JK, Yaffe K, Glenn S, Rosen HJ, Miller BL (2006) Multiple cognitive deficits in amnestic mild cognitive impairment. Dement Geriatr Cogn Disord. 22(4):306–311
doi: 10.1159/000095303
Kessels RPC, Molleman PW, Oosterman JM (2011) Assessment of working-memory deficits in patients with mild cognitive impairment and Alzheimer’s dementia using Wechsler’s Working Memory Index. Aging Clin Exp Res 23(5–6):487–490
doi: 10.1007/BF03325245
Petersen RC, Smith GE, Ivnik RJ, Kokmen E, Tangalos EG (1994) Memory function in very early Alzheimer’s disease. Neurology. 44(5):867–872
doi: 10.1212/WNL.44.5.867
Estévez-González A, García-Sánchez C, Boltes A, Otermín P, Pascual-Sedano B, Gironell A, Kulisevsky J (2004) Semantic knowledge of famous people in mild cognitive impairment and progression to Alzheimer’s disease. Dement Geriatr Cogn Disord 17(3):188–195
doi: 10.1159/000076355
Arango-Lasprilla JC, Cuetos F, Valencia C, Uribe C, Lopera F (2007) Cognitive changes in the preclinical phase of familial Alzheimer’s disease. J Clin Exp Neuropsychol 29:892–900
doi: 10.1080/13803390601174151
Thompson SA, Graham KS, Patterson K, Sahakian BJ, Hodges JR (2002) Is knowledge of famous people disproportionately impaired in patients with early and questionable Alzheimer’s disease? Neuropsychology. 16(3):344–358
doi: 10.1037/0894-4105.16.3.344
García S, Cuetos F, Novelli A, Martínez C (2020) Famous faces naming test predicts conversion from mild cognitive impairment to Alzheimer’s disease. Acta Neurol Belg. https://doi.org/10.1007/s13760-020-01483-3

Auteurs

Sara García (S)

Department of Psychology, University of Oviedo, Plaza Feijoo, s/n, 33003, Oviedo, Spain. saraggps@gmail.com.

Fernando Cuetos (F)

Department of Psychology, University of Oviedo, Plaza Feijoo, s/n, 33003, Oviedo, Spain.

Antonello Novelli (A)

Department of Psychology, University of Oviedo, Plaza Feijoo, s/n, 33003, Oviedo, Spain.
Institute of Biotechnology, University of Oviedo, Campus del Cristo, Edificio Santiago Gascón, 33006, Oviedo, Spain.
Institute for Sanitary Research of the Princedom of Asturias (ISPA), Oviedo, Spain.

Carmen Martínez (C)

University Hospital of Cabueñes, Calle Los Prados, n° 395, 33203, Gijón, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH